A Single-arm Pilot Study of Tislelizumab Combined With Anlotinib in Patients With Advanced NSCLC With Driver-negative After Progression to Immunotherapy
Conditions: Advanced NSCLC Interventions: Drug: Tislelizumab; Drug: Anlotinib Sponsors: The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Short-term Effect of Podiatric Callus Debridement on Plantar Pressure in Diabetic Neuropathic Patients
Conditions: Diabetic Neuropathies; Plantar Callus Interventions: Procedure: Callus debridement Sponsors: Chinese University of Hong Kong; Princess Margaret Hospital, Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Buyuan-zhixiao Formula in the Treatment of Elderly Patients With Diabetes and Multiple Metabolic Disorders
Conditions: Diabete Mellitus; Aging; Metabolic Disorders; Traditional Chinese Medicine; Randomized Controlled Trial Interventions: Drug: Buyuan Zhixiao Formula; Drug: Placebo Sponsors: Qing Ni Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Clinical Study of Desuzumab in the Treatment of Knee Osteoarthritis
Conditions: Knee Osteoarthritis Interventions: Drug: Denosumab Sponsors: Wuhan Union Hospital, China Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Rehabilitation After Direct Anterior Approach for Total Hip Arthroplasty
Conditions: Total Hip Arthroplasty Interventions: Other: Pre- and post-operation physical therapy Sponsors: China Medical University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Safety and efficacy of ketorolac in improving the prognosis of acute type A aortic dissection patients: a protocol of a randomized, double-blinded, and placebo-controlled study
This study is a single-center, randomized, double-blinded, and placebo-controlled study. A total of 120 patients with aTAAD will be recruited and will be randomized into the ketorolac group and placebo group with a ratio of 1:1. Ketorolac tromethamine 60 mg per 2 ml will be intramuscularly injected within 2 h before surgery, followed by intramuscular injections of 30 mg per 1 ml BID. on the first and second postoperative days in the Ketorolac group, while 0.9% saline will be administered at the same dose, dosage form, and time in the placebo g roup. This study aims to evaluate the safety and efficacy of ketorolac in ...
Source: Trials - April 10, 2024 Category: Research Source Type: clinical trials
Outcomes of Concomitant Bypass Surgery in Septal Myectomy
Conditions: Hypertrophic Cardiomyopathy; Coronary Artery Disease; Myocardial Bridging Interventions: Procedure: CABG during myectomy Sponsors: Chinese Academy of Medical Sciences, Fuwai Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Clinical Applications of Integrated PET/MR and PET/CT in the Diagnosis and Treatment of Prostate Cancer.
Conditions: Prostate Cancer; Pet-ct Interventions: Drug: 68Ga-PSMA Sponsors: The First Affiliated Hospital of Anhui Medical University; National Natural Science Foundation of China Suspended (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Transhiatal Tunnel Valvuloplasty for Reconstruction Following the Laparoscopic Proximal Gastrectomy
Conditions: Proximal Gastrectomy; Gastric Tube; Valvulopathy Interventions: Procedure: the Transhiatal Tunnel Valvuloplasty technique Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Alectinib in Combination With Nivolumab in the Treatment of Recurrent or Refractory HCC Patients Guided With Serum RNase1 and Tumor Expression of PD-L1
Conditions: Hepatocellular Carcinoma Interventions: Drug: Alectinib (Alecensa), Nivolumab (Opdivo) Sponsors: China Medical University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Electroacupuncture of Different Treatment Frequency in Chronic Urinary Retention Caused by Lower Motor Neuron Lesions
Conditions: Urinary Retention; Lower Motor Neurone Lesion Interventions: Device: Electroacupuncture of 2 sessions per week; Device: Electroacupuncture of 3 sessions per week; Device: Electroacupuncture of 4 sessions per week Sponsors: Guang ' anmen Hospital of China Academy of Chinese Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Pilot Study of Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China
Conditions: Breast Neoplasm Female; Financial Toxicity; Financial Navigation Interventions: Behavioral: Financial Navigation; Other: Usual Care Sponsors: Fudan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Effectiveness of an Online Intervention Using a Feminist Approach on Gender Equality Promotion and Sexual Violence Prevention in China
Conditions: Sexual Violence Interventions: Behavioral: Sexual Violence Prevention; Behavioral: Sexual health intervention Sponsors: The University of Hong Kong Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Epidemiological Investigation of Malocclusion in China
Conditions: Epidemiological Investigation; Malocclusion Sponsors: Shanghai Jiao Tong University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
Real-world Study of CHina Ozempic cLinicAl pRactice in Patients With Type 2 Diabetes (SCHOLAR)
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: Semaglutide Sponsors: Novo Nordisk A/S Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
